Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis

Hepatology

Volumn 28, Issue 1, 1998, Pages 231-236

  Huo, Teh Ia ^a   Wu, Jaw Ching ^a,b   Lee, Pui Ching ^a   Chau, Gar Yang ^b   Lui, Wing Yu ^b   Tsay, Shyh Haw ^b   Ting, Ling Tan ^b   Chang, Full Young ^a   Lee, Shou Dong ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA FETOPROTEIN; HEPATITIS ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; IMMUNOGLOBULIN M ANTIBODY; VIRUS DNA;

ADULT; AGED; ARTICLE; CHRONIC HEPATITIS; DISEASE CARRIER; ECHOGRAPHY; ENZYME IMMUNOASSAY; FEMALE; FOLLOW UP; HEPATITIS B; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; RADIOIMMUNOASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR;

ADULT; ALANINE TRANSAMINASE; ANTIGENS, DIFFERENTIATION; CARCINOMA, HEPATOCELLULAR; CARRIER STATE; CHRONIC DISEASE; DNA, VIRAL; FEMALE; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; RISK FACTORS;

EID: 0031837430     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510280130     Document Type: Article

References (22)

1. Sampliner RE, Hamilton FA, Iseri OA, Tabor E, Boitnott J. The liver histology and frequency and clearance of the hepatitis B surface antigen (HBsAg) in chronic carriers. Am J Med Sci 1979;277:17-22.
2. Alward WLM, McMahon BJ, Hall DB, Heyward WL, Franchis DP, Bender TR. The long-term serological course of asymptomatic hepatitis B virus carriers and the development of primary hepatocellular carcinoma. J Infect Dis 1985;151:604-609.
3. Da Silva LC, De Assis Madruga CL, Carrilho FJ, Pinho JRR, Saez-Alquezar A, Santos C, Bassit L, et al. Spontaneous hepatitis B surface antigen clearance in a long-term follow-up study of patients with chronic type B hepatitis: lack of correlation with hepatitis C and D virus infection. J Gastroenterol 1996;31:696-701.
4. Viola LA, Barrison IG, Coleman JC, Paradinas FJ, Fluker JL, Evans BA, Murray-Lyon IM. Natural history of liver disease in chronic hepatitis B surface antigen carriers. Lancet 1981;2:1156-1159.
5. Lindsay KL, Redeker AG, Ashcavai M. Delayed HBsAg clearance in chronic hepatitis B viral infection. HEPATOLOGY 1981;l:586-589.
6. Dormeyer HH, Arnold W, Schonborn H, Braun B, Klinge O, Pfeifer U, Knolle J, et al. The significance of serologic, and immunologic findings in the prognosis of 88 asymptomatic carriers of hepatitis B surface antigen. J Infect Dis 1981;144:33-37.
7. Morgan TR, Redeker AG, Yamada S, Ashcavai M. HBsAg clearance in chronic active hepatitis B: a possible cause of cryptogenic cirrhosis. Dig Dis Sci 1986;31:700-704.
8. Poralla T, Manns M, Hutteroth TH, Hess G, Dormeyer HH, Meyerzum Buschenfelde K-H. HBsAg clearance in patients with longstanding chronic active hepatitis B and hepatitis B virus induced liver cirrhosis. Digestion 1986;33:53-60.
9. Dragosics B, Ferenci P, Hitchman E, Denk H. Long-term follow-up study of asymptomatic HBsAg-positive voluntary blood donors in Austria: a clinical and histologie evaluation of 242 cases. HEPATOLOGY 1987;7:302-306.
10. Beasly RP, Huang LY, Lin CC, Leu ML, Stevens CE, Szmuness W, Chen KP. Incidence of hepatitis B virus infections in preschool children in Taiwan. J Infect Dis 1982;146:198-204.
11. Stevens CE, Beasley RP, Tsui J, Lee WC. Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med 1975;292:771-774.
12. Wu TT, Hsu HC, Chen DS, Sheu JC, Su IJ, Chen SL, Chung SM. Clearance of hepatitis B surface antigen (HBsAg) after surgical resection of hepatocellular carcinoma. J Hepatol 1987;4:45-51.
13. Liaw YF, Sheen IS, Chen TJ, Chu CM, Pao CC. Incidence, determinants and significance of delayed clearance of serum HBsAg in chronic hepatitis B virus infection: a prospective study. HEPATOLOGY 1990;13:627-631.
14. Feinman SV, Berris B, Cooter N, Sinclair JC, Wrobel DM. Results of a long-term prospective study of hepatitis B surface antigen (HBsAg) carrier state. Hepatogastroenterology 1982;29:58-61.
15. Brechot C, Degos F, Lugassy C, Thiers V, Zafrani S, Bismuth FD. Hepatitis B virus DNA in patients with chronic liver disease and negative tests for hepatitis B surface antigen. N Engl J Med 1985;312:270-276.
16. Adachi H, Kaneko S, Matsushita E, Inagaki Y, Unoura M, Kobayashi K. Clearance of HBsAg in seven patients with chronic hepatitis B. HEPATOLOGY 1992;16:1334-1337.
17. Bernuau J, Rueff B, Benhamou JP. Fulminant and subfulminant liver failure: definition and causes. Semin Liver Dis 1986;6:97-106.
18. Sheu JC, Huang GT, Shih LN, Lee WC, Chou HC, Wang JT, Lee PH, et al. Hepatitis C and B viruses in hepatitis B surface antigen-negative hepatocellular carcinoma. Gastroenterology 1992;103:1322-1327.
19. Gross-Bellard M, Oudet P, Chambon P. Isolation of high-molecular-weight DNA from mammalian cells. Eur J Biochem 1973;36:32-38.
20. Wu JC, Lin HC, Jeng FS, Ma GY, Lee SD, Sheng WY. Prevalence, infectivity and risk factor analysis of hepatitis C virus infection in prostitutes. J Med Virol 1993;39:312-317.
21. Chao YC, Lee CM, Tang HS, Govindarajan S, Lai MMC. Molecular cloning and characterization of an isolate of hepatitis delta virus from Taiwan. HEPATOLOGY 1991;13:345-352.
22. Wu JC, Chen CL, Hou MC, Chen TZ, Lee SD, Lo KJ. Multiple virus infection as the most common cause of fulminant and subfulminant viral hepatitis in an area endemic for hepatitis B: application and limitation of the polymerase chain reaction. HEPATOLOGY 1993;19:836-840.